Glutamate signaling plays a significant role in the pathophysiology of HD, and the pharmacological blockade of mGluR5 using NAMs delays disease progression in male zQ175 HD mice (Abd-Elrahman et al., 2017). The gene discussed is GRM5; the disease is Huntington disease.